Ryosuke Oki

Efficacy and Safety of Ultrahigh-Dose Methylcobalamin in Early-Stage Amyotrophic Lateral Sclerosis

Ryosuke Oki, Yuishin Izumi, Koji Fujita et al. · JAMA Neurology · 2022 · 83 citations · Full text

Medicine, Neurology, Pharmacology +13

Safety and tolerability of bosutinib in patients with amyotrophic lateral sclerosis (iDReAM study): A multicentre, open-label, dose-escalation phase 1 trial

Keiko Imamura, Yuishin Izumi, Makiko Nagai et al. · EClinicalMedicine · 2022 · 53 citations · Full text

Medicine, Neurology, Pharmacology +16

Induced pluripotent stem cell–based Drug Repurposing for Amyotrophic lateral sclerosis Medicine (iDReAM) study: protocol for a phase I dose escalation study of bosutinib for amyotrophic lateral sclerosis patients

Keiko Imamura, Yuishin Izumi, Haruhiko Banno et al. · BMJ Open · 2019 · 48 citations · Full text

Medicine, Neurology, Pharmacology +17

Phenotype variability and allelic heterogeneity in KMT2B-Associated disease

Toshitaka Kawarai, Ryosuke Miyamoto, Eiji Nakagawa et al. · Parkinsonism & Related Disorders · 2018 · 40 citations

Life Sciences, Genetics, Molecular Genetics +12

Novel Combined GPIHBP1 Mutations in a Patient with Hypertriglyceridemia Associated with CAD

Hiroyasu Yamamoto, Misa Onishi, Naoko Miyamoto et al. · Journal of Atherosclerosis and Thrombosis · 2013 · 29 citations · Full text

Medicine, Cardiology, Genetics +17